Loading…
Charming Medical Ltd
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in MCTA.
▲ +24.9% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 2 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 |
|---|---|---|---|
| Year-end price | $29.35 | $29.35 | |
| P/E | — | — | 366.9x |
| P/S | — | 98.6x | 72.4x |
| P/B | — | 91.5x | 9143.4x |
| EPS | $0.00 | $0.08 | |
| Profit margin | — | -0.47% | 19.27% |
| ROE | — |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SPRYARS Pharmaceuticals, Inc. | $4.48 | — | 35.6x | — | -210.35% | $445.52M |
| RZLTRezolute, Inc. | $4.62 | — | 4.1x | — | -81.73% | $444.87M |
| QTTBQ32 Bio Inc. | $15.03 | 4.8x | 3.4x | — | 72.14% | $447.44M |
| BIOABioAge Labs, Inc. | $9.65 |
Charming Medical Limited, through its subsidiaries, provides beauty and wellness services and products in Hong Kong. The company offers beauty, wellness, and postpartum services, including womb-warming therapy, agarwood moxibustion therapy, traditional chinese medicine (TCM) inspired prenatal massage, and indonesian traditional abdominal binding, as well as beauty, tailor-made, slim (BTS) pelvic detox therapy. It also provides TCM-inspired women's wellness services targeting women of different age groups through its wellness centers; non-hormonal induced lactation therapy, national moisturizing facial, saffron hip therapy, and natural reishi mushroom breast care; and japanese-style facial bone adjustment, needle-free thread embedding, and imperial chinese herbal acne detox therapy. In addition, the company offers TCM head/eyed care therapy services comprising ultrasound therapy, forehead cupping therapy, traditional herbal deer antler hair care, deep cleansing follicle therapy, japanese scalp cleansing, cell activation hair growth therapy, and TCM e-plus eye care therapy; and forehead and temples cupping, hair follicle deep cleaning, TCM deer antler hair care, and hair follicle activation therapies, as well as ultrasonic therapy device. Further, it provides Beauty Lab home herbal uterine care patch; probiotic intimate wash; Yin-nourishing pill; Ginseng soothing anti-allergy moisturizing wash; and southern european olive leaf extract for hair anti-aging and hair loss prevention. Additionally, the company is involved in the provision of consultancy services; and franchise activities. It serves women aged between twenty-five to fifty-five through online and offline channels. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Company description provided by Yahoo Finance.
| -0.44% |
| 2435.04% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 1.2x |
| — |
| -28.21% |
| $442.91M |
| EPRXEupraxia Pharmaceuticals Inc | $6.68 | — | 4.3x | — | -66.70% | $441.04M |
| AVIRAtea Pharmaceuticals, Inc. | $5.64 | — | 2.2x | — | -58.14% | $452.35M |